Electronic clinical thermometer
    5.
    发明申请
    Electronic clinical thermometer 审中-公开
    电子体温计

    公开(公告)号:US20060082947A1

    公开(公告)日:2006-04-20

    申请号:US11255517

    申请日:2005-10-19

    IPC分类号: H01H73/00

    CPC分类号: G01K13/002 G01K2215/00

    摘要: In turn-on state, it is monitored whether a power switch 15 is pressed or not (ST1). When not pressed, it is continuously monitored whether pressed or not. When it is judged that the power switch 15 is pressed, it is monitored whether the power switch 15 is pressed continuously for no less than 2 seconds or not (ST2). When it is judged that the power switch 15 is not pressed continuously for no less than 2 seconds, back to ST1, it is continuously monitored whether the power switch 15 is pressed or not. When it is judged that the power switch 15 is pressed continuously for no less than 2 seconds, the process of turning off the power is started (ST3).

    摘要翻译: 在接通状态下,监视电源开关15是否被按下(ST1)。 未按下时,不管是否按下,都会持续监控。 当判断按下电源开关15时,监视电源开关15是否连续按压不少于2秒(ST2)。 当判断电源开关15未连续按压不少于2秒钟时,回到ST1,连续监视电源开关15是否被按下。 当判断电源开关15连续按压不少于2秒时,开始关闭电源的处理(ST3)。

    POROUS CRYSTALLINE SACCHARIDE, ITS PREPARATION AND USES
    6.
    发明申请
    POROUS CRYSTALLINE SACCHARIDE, ITS PREPARATION AND USES 有权
    多孔晶体,其制备和用途

    公开(公告)号:US20100222569A1

    公开(公告)日:2010-09-02

    申请号:US12159166

    申请日:2006-12-25

    IPC分类号: C13K7/00

    CPC分类号: C13K7/00 C13K13/00

    摘要: An object of the present invention is to provide a crystalline saccharide having novel physical properties, a preparation and uses thereof. The present invention solves the above objects by providing a porous crystalline saccharide having a number of pores, a process for producing the same, comprising the step of keeping hydrous crystalline saccharide at an ambient temperature or higher in an organic solvent for the dehydration, and the use thereof.

    摘要翻译: 本发明的目的是提供具有新物理性质的结晶糖,其制备和用途。 本发明通过提供具有多个孔的多孔结晶性糖类及其制造方法来解决上述目的,其包括将有机溶剂中的含水结晶糖保持在环境温度以上以进行脱水的工序, 使用它。

    .beta.-fructofuranosidase its preparation and uses
    8.
    发明授权
    .beta.-fructofuranosidase its preparation and uses 失效
    β-呋喃果糖苷酶的制备和用途

    公开(公告)号:US5837527A

    公开(公告)日:1998-11-17

    申请号:US941552

    申请日:1997-09-30

    摘要: A .beta.-fructofuranosidase with a molecular weight of 49,000.+-.5,000 daltons on SDS-PAGE, an isoelectric point of 4.6.+-.0.5, an optimum pH of about 5.5-6.0, and an optimum temperature of about 50.degree. C. in the presence of calcium ion. The enzyme acts on saccharides with a .beta.-fructofuranosidic linkage and other substances including other saccharides, sugar alcohols, and alcohols to produce fructosyl-transferred saccharides in a relatively high yield.

    摘要翻译: 在SDS-PAGE上的分子量为49,000 +/- 5,000道尔顿的β-呋喃果糖苷酶,等电点为4.6 +/- 0.5,最适pH为约5.5-6.0,最适温度为约50℃ 钙离子的存在。 该酶作用于具有β-呋喃果糖苷键的糖类和其它物质,包括其它糖类,糖醇和醇类,以相当高的产率产生果糖基转移的糖类。

    .alpha.-glycosyl derivative of catecholamine or its salt, and its
preparation and uses
    9.
    发明授权
    .alpha.-glycosyl derivative of catecholamine or its salt, and its preparation and uses 失效
    儿茶酚胺或其盐的α-糖基衍生物及其制备和用途

    公开(公告)号:US5618794A

    公开(公告)日:1997-04-08

    申请号:US483260

    申请日:1995-06-07

    摘要: Disclosed is a novel .alpha.-glycosyl derivative of a catecholamine or its salt, said .alpha.-glycosyl derivative being prepared by allowing a saccharide-transferring enzyme together with or without glucoamylase to act on a solution containing an .alpha.-glycosyl saccharide and one of catecholamines in order to form an .alpha.-glycosyl derivative of said catecholamines, and recovering the resultant .alpha.-glycosyl derivative. The .alpha.-glycosyl derivative overcomes conventional drawbacks of catecholamines, and does not substantially exhibit or have a reducing activity and undesirable toxicity, but has a relatively-high stability and exerts the inherent physiological activities of catecholamines in vivo. Thus, the .alpha.-glycosyl derivative is advantageously used as a variety of pharmaceuticals in the form of an injection, tablet, etc.

    摘要翻译: 公开了一种儿茶酚胺或其盐的新型α-糖基衍生物,所述α-糖基衍生物通过使糖转移酶与或不与葡糖淀粉酶一起作用于含有α-糖基糖和一种儿茶酚胺的溶液来制备 以形成所述儿茶酚胺的α-糖基衍生物,并回收所得的α-糖基衍生物。 α-糖基衍生物克服了儿茶酚胺的常规缺点,并且基本上不显示或具有还原活性和不期望的毒性,但具有相对高的稳定性并且在体内发挥儿茶酚胺的固有生理活性。 因此,α-糖基衍生物有利地用作注射剂,片剂等形式的多种药物。

    .beta.-fructofuranosidase, its preparation and uses
    10.
    发明授权
    .beta.-fructofuranosidase, its preparation and uses 失效
    β-呋喃果糖苷酶,其制备和用途

    公开(公告)号:US5952204A

    公开(公告)日:1999-09-14

    申请号:US941551

    申请日:1997-09-30

    摘要: A .beta.-fructofuranosidase with a molecular weight of 49,000.+-.5,000 daltons on SDS-PAGE, an isoelectric point of 4.6.+-.0.5, an optimum pH of about 5.5-6.0, and an optimum temperature of about 50.degree. C. in the presence of calcium ion. The enzyme acts on saccharides with a .beta.-fructofuranosidic linkage and other substances including other saccharides, sugar alcohols, and alcohols to produce fructosyl-transferred saccharides in a relatively high yield.

    摘要翻译: 在SDS-PAGE上的分子量为49,000 +/- 5,000道尔顿的β-呋喃果糖苷酶,等电点为4.6 +/- 0.5,最适pH为约5.5-6.0,最适温度为约50℃ 钙离子的存在。 该酶作用于具有β-呋喃果糖苷键的糖类和其它物质,包括其它糖类,糖醇和醇类,以相当高的产率产生果糖基转移的糖类。